colon cancer tissues; adjacent normal colonic tissues
HCT116; RKO; SW620; HT29; SW480; NCM460; 293T
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; ISH (In Situ Hybridization); Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; ChIP / ChIP-seq; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Transwell Assay; In Vivo Animal Model; H&E Staining; Western Blot; Cohort Study; Survival Analysis; ROC Analysis; Bioinformatics Analysis
Low circHIPK2 expression was associated with high tumor grade, high TNM stage, poor patient survival, and diagnostic value for colon cancer screening; circHIPK2 may serve as a diagnostic/prognostic biomarker.
circHIPK2 is a human HIPK2-derived circRNA downregulated in colon cancer. It suppresses colon cancer proliferation, migration, invasion, tumor growth, and metastasis by sponging miR-373-3p, thereby increasing RGMA and activating BMP/Smad signaling. Clinically, low circHIPK2 expression is associated with higher tumor grade/stage and poorer survival, supporting its potential diagnostic and prognostic value.
0.8999
Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p/RGMA axis.
combined biological and clinical study